MyShare
Assets: cash current-assets inventory receivables investments invested ppe nta assets net-debt working-capital liabilities long-term-debt accounts-payable non-current-liabilities
Income sheet sales operations-income gross-profit | expenses marketing r-and-d income-before-tax tax income net-income interest-income ebit leases interest earnings
Other shares shares-outstanding treasury-stock equity buyback | dividends | free-cash-flow change-in-cash
IBM r-and-d - Research and Development for None
Research and Development is the amount the company has spent figuring out designing new products and ways to build them
- IBM r-and-d for the quarter ending Dec 31, 2023 since 4 quarters ago, have risen by 8.98%, from $1604.0 million to $1748.0 million this quarter. This marks a growth from last quarter, when they were up 3.74% from $1685.0 million.
- IBM r-and-d for the quarter ending Sep 30, 2023 were down 0.1% to $1685.0 million from $1687.0 million last quarter.
- IBM r-and-d for the quarter ending Jun 30, 2023 have been rising for the past 5 quarters and were up 1.93% from $1655.0 million last quarter to $1687.0 million this quarter.
- IBM r-and-d for the quarter ending Mar 31, 2023 were up 3.2% from $1604.0 million last quarter to $1655.0 million.
- IBM r-and-d for the quarter ending Dec 31, 2022 for this quarter fiscal quarter were down 0.43% from the previous quarter, totaling $1604.0 million. This marks a continued decline from 3 quarters ago, when they were $1679.0 million.
IBM Research and Development
| quarter ending | IBM Research and Development | percent change | percent of market cap | per share | total shares |
|---|---|---|---|---|---|
| Dec 31, 2023 | 1748.0M | up 3.7% | 1.01 | 2.93 | 59643000000.0 |
| Sep 30, 2023 | 1685.0M | down 0.1% | 0.97 | 2.84 | 59313000000.0 |
| Jun 30, 2023 | 1687.0M | up 1.9% | 0.97 | 2.86 | 58963000000.0 |
| Mar 31, 2023 | 1655.0M | up 3.2% | 0.96 | 2.82 | 58675000000.0 |
| Dec 31, 2022 | 1604.0M | down 0.4% | 0.93 | 2.75 | 58343000000.0 |
| Sep 30, 2022 | 1611.0M | down 3.7% | 0.93 | 2.77 | 58117000000.0 |
| Jun 30, 2022 | 1673.0M | down 0.4% | 0.97 | 2.89 | 57802000000.0 |
| Mar 31, 2022 | 1679.0M | up 3.3% | 0.97 | 2.91 | 57603000000.0 |
| Dec 31, 2021 | 1625.0M | up | 0.94 | 2.84 | 57319000000.0 |
| Sep 30, 2021 | 1621.0M | down 2.2% | 0.94 | 2.83 | 57189000000.0 |
| Jun 30, 2021 | 1657.0M | up 1.7% | 0.96 | 2.91 | 56912000000.0 |
| Mar 31, 2021 | 1630.0M | up 1.2% | 0.94 | 2.87 | 56788000000.0 |
| Dec 31, 2020 | 1611.0M | up 6.3% | 0.93 | 2.85 | 56556000000.0 |
| Sep 30, 2020 | 1515.0M | down 4.2% | 0.88 | 2.69 | 56366000000.0 |
| Jun 30, 2020 | 1582.0M | down 2.6% | 0.91 | 2.82 | 56135000000.0 |
None Research and Development actual and forcast
The green bars show the actual Research and Development for None. The blue bars is the forcast for the next quarter.
Comparison of None Research and Development with other stocks
To compare Research and Development accross stocks, we can compare a number of metrics including the Research and Development, and the Research and Development yeild.
``` ```